Science Explorer Back to mapMap
Discussion
Topic · Health

Vaccine Coverage and Hesitancy

Vaccine Coverage and Hesitancy is a research topic within Health. Science Explorer counts 38k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers explores the multifaceted issue of vaccine hesitancy, including its determinants, impact on immunization coverage, and implications for global health. It delves into factors such as risk perception, herd immunity, and the influence of social media on vaccination attitudes. The research also addresses strategies to improve vaccine acceptance and access, highlighting the importance of trust in vaccination efforts.

  • Vaccine Hesitancy
  • COVID-19 Vaccine
  • Health Behavior
  • Risk Perception
  • Herd Immunity
  • Vaccination Intention
  • Global Access
  • Social Media
  • Trust in Vaccination
  • Immunization Coverage
Research works
38k
fractional, since 1950
In the world top 10%
3.9k
per year above
Top-10% rate
10.0%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+59%
the tick is no change
Largest producer
United States
41% of the 10 largest, 2022-now

Which countries lead Vaccine Coverage and Hesitancy research?

By volume, the United States and India publish the most (3.8k and 859 works in 2022-now).

By volume, 2022-now

  1. 1 United States 3.8k works
  2. 2 India 859 works
  3. 3 China 798 works
  4. 4 United Kingdom 795 works
  5. 5 Brazil 627 works
  6. 6 Indonesia 551 works
  7. 7 Canada 502 works
  8. 8 Italy 424 works
  9. 9 Türkiye 408 works
  10. 10 Australia 408 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 41.4%India: 9.4%China: 8.7%United Kingdom: 8.7%6 others listed: 31.8%41%largest
United States3,798 · 41.4%India859 · 9.4%China798 · 8.7%United Kingdom795 · 8.7%6 others listed2,920 · 31.8%

Shares of the rows listed above, not of the whole node.

Which institutions lead Vaccine Coverage and Hesitancy research?

By volume in 2022-now, University of North Carolina at Chapel Hill publishes the most Vaccine Coverage and Hesitancy research, followed by United States Department of Health and Human Services and World Health Organization.

Who are the leading researchers in Vaccine Coverage and Hesitancy?

The most-cited researchers publishing on Vaccine Coverage and Hesitancy include David Moher, Christopher J L Murray and Simon Iain Hay.

  1. 1 David Moher Canada 898k citations
  2. 2 Christopher J L Murray United States 583k citations
  3. 3 Simon Iain Hay United States 452k citations
  4. 4 George Davey Smith United Kingdom 435k citations
  5. 5 Ali H. Mokdad United States 429k citations
  6. 6 Julian P. T. Higgins United Kingdom 390k citations
  7. 7 Zulfiqar Ahmed Bhutta Pakistan 371k citations
  8. 8 Hermann Brenner Germany 343k citations
  9. 9 Matthias Egger Switzerland 326k citations
  10. 10 John P. A. Ioannidis United States 317k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Vaccine Coverage and Hesitancy?

The most cited paper in Vaccine Coverage and Hesitancy is "Vaccine hesitancy: Definition, scope and determinants" (Noni E. MacDonald, 2015), with 5,786 citations. Next come "Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK" (5,030) and "Knowledge, attitudes, and practices towards COVID-19 among Chinese residents during the rapid rise period of the COVID-19 outbreak: a quick online cross-sectional survey" (3,279).

Most cited papers
#PaperReleasedCitations
1 Vaccine hesitancy: Definition, scope and determinants Noni E. MacDonald · Vaccine Open access 17 Apr 2015 5,786
2 Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK Merryn Voysey et al. · The Lancet Open access765 authors 8 Dec 2020 5,030
3 Knowledge, attitudes, and practices towards COVID-19 among Chinese residents during the rapid rise period of the COVID-19 outbreak: a quick online cross-sectional survey Bao‐Liang Zhong, Wei Ping Luo, Hai-Mei Li et al. · International Journal of Biological Sciences Open access 2020 3,279
4 A global survey of potential acceptance of a COVID-19 vaccine Jeffrey Victor Lazarus, Scott C. Ratzan, Adam Palayew et al. · Nature Medicine Open access 20 Oct 2020 3,081
5 Trained immunity: A program of innate immune memory in health and disease Mihai Gheorghe Netea, Leo A. B. Joosten, Eicke Latz et al. · Science Open access 21 Apr 2016 2,825
All 100 most cited papers, with filters and sorting

Where is Vaccine Coverage and Hesitancy research done?

The largest centres of Vaccine Coverage and Hesitancy research in 2022-now are London (United Kingdom), New York (United States), Atlanta (United States) and Chapel Hill (United States). Among places with at least 20 works in it, it is an unusually large share of all research in Rahway.

Largest cities, 2022-now

  1. 1 LondonUnited Kingdom 324 works
  2. 2 New YorkUnited States 198 works
  3. 3 AtlantaUnited States 172 works
  4. 4 Chapel HillUnited States 167 works
  5. 5 BeijingChina 152 works
  6. 6 Washington D.C.United States 133 works
  7. 7 BaltimoreUnited States 117 works
  8. 8 ParisFrance 114 works
  9. 9 São PauloBrazil 114 works
  10. 10 BostonUnited States 113 works

Where it is the local speciality

  1. RahwayUS · 24.2 works19×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Vaccine Coverage and Hesitancy than the world average.

See Vaccine Coverage and Hesitancy on the map

Where is the best place to study Vaccine Coverage and Hesitancy?

Among universities, judged by research, London School of Hygiene & Tropical Medicine, Johns Hopkins University and Harvard University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 19.78%fractional works in this field (log) →share of work in the world top 10% →University of GondarLondon School of Hyg…Harvard UniversityJohns Hopkins Univer…
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1London School of Hygiene & Tropical MedicineUnited Kingdom 78.819.6%30.4×64 +8.9%
2Johns Hopkins UniversityUnited States 68.615.9%4.7×97 +52.3%
3Harvard UniversityUnited States 68.416.7%2.0×86 +27.0%
4University of GondarEthiopia 68.227.0%13.4×26 +54.5%
5Radboud University NijmegenNetherlands 67.929.9%2.0×16 +68.5%
6University College LondonUnited Kingdom 65.521.2%1.9×41 +38.3%
7University of WashingtonUnited States 63.718.3%3.2×48 +42.4%
8Chinese University of Hong KongChina 63.018.1%3.0×29 +72.5%
9University of Hong KongChina 62.917.3%2.4×30 +94.3%
10University of TorontoCanada 62.113.8%2.3×62 +63.6%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Vaccine Coverage and Hesitancy, country by country

Is Vaccine Coverage and Hesitancy research growing?

Output in 2022-2025 was 59% higher than in 2018-2021, peaking in 2022. The fastest-growing topics are Vaccine Coverage and Hesitancy.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Vaccine Coverage and Hesitancy as a percentage of every work published that year, 0.058% in 2024.

still counting0.050%0.10%Vaccine Coverage and Hesitancy0.049% in 202519801990200020102020

Fractional works of Vaccine Coverage and Hesitancy over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Vaccine Coverage and Hesitancy10.2% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Questions people ask

Who researches vaccine hesitancy?

By volume in 2022-now, University of North Carolina at Chapel Hill publishes the most Vaccine Coverage and Hesitancy research, followed by United States Department of Health and Human Services and World Health Organization. By volume, the United States and India publish the most (3.8k and 859 works in 2022-now).

All 1,273 questions in the Question Catalogue

Discussion

Ask a question or share a note about Vaccine Coverage and Hesitancy. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.